·] Shares KAMADA LTD. ORDINARY SHARES, PAR VALUE NIS 1.00 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations • New York
TECHNOLOGY LICENSE AGREEMENT BY AND AMONG KAMADA LTD. AND BAXTER HEALTHCARE S.A. DATED: AUGUST 23, 2010 TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations • New York
THIS TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is made and entered into as of 5:00 PM Eastern Daylight Time, August 23, 2010 (the “Effective Date”), by and among Kamada, Ltd., an Israeli corporation, having a principal place of business at Science Park, Kiryat Weizmann, 7 Sapir Street, P.O. Box 4081, Ness Ziona 74140, Israel (“Kamada”) and Baxter Healthcare SA (“Baxter”) a Swiss corporation having a principal place of business at Postfach, 8010, Zurich, Switzerland.
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations • England
This EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of August 2, 2012 (the “Effective Date”) by and between Kamada Ltd., an Israeli corporation (collectively with its Affiliates, “Kamada”), whose principal office is at Science Park, Kiryat Weizmann, 7 Sapir Street, Ness Ziona 74140, Israel, and Chiesi Farmaceutici S.p.A (“Chiesi”), an Italian corporation whose registered office is at Via Palermo 26/A, 43122 Parma, Italy.
FIRST AMENDMENT TO THE TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations
This First Amendment to the Technology License Agreement dated August 23rd, 2010 by and between Baxter Healthcare SA, a Swiss corporation having a principal place of business at Postfach, 8010, Zurich, Switzerland (hereinafter “Baxter”) and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter “Kamada”) (the “Agreement”) is entered into as of this 14th day of May, 2013 (the “Effective Date”). Baxter and Kamada shall collectively be referred to as the “Parties”.
EXCLUSIVE MANUFACTURING, SUPPLY AND DISTRIBUTION AGREEMENTExclusive Manufacturing, Supply and Distribution Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations • New York
This EXCLUSIVE MANUFACTURING, SUPPLY AND DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of 5:00 PM Eastern Daylight Time, August 23, 2010 (the “Effective Date”) by and between Kamada Ltd., an Israeli corporation (collectively with its Affiliates, “Kamada”), whose principal office is at Science Park, Kiryat Weizmann, 7 Sapir Street, P.O. Box 4081, Ness Ziona 74140, Israel, and Baxter Healthcare Corporation (“Baxter”), a Delaware corporation whose principal office is at One Baxter Parkway, Deerfield, Illinois 60015, USA.
SIDE LETTER AGREEMENTSide Letter Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations
This Side Letter Agreement (this “Letter Agreement”) is made as of March 23, 2011, by and between, Kamada Ltd. (“Kamada”), an Israeli corporation whose principal office is at 7 Sapir St., Science Park, Kiryat Weizmann, Ness Ziona, 74036, Israel, and Baxter Healthcare Corporation (“Baxter”), a Delaware corporation whose principal office is at One Baxter Parkway, Deerfield, Illinois 60015, USA. Capitalized terms used but not defined herein shall have the meanings assigned to them in the Agreements (as hereinafter defined).
September 6, 2012 Kamada Ltd. Science Park Kiryat WeizmannSupply and Distribution Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations
SECOND AMENDMENT TO THE EXCLUSIVE MANUFACTURING, SUPPLY AND DISTRIBUTION AGREEMENTSupply and Distribution Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations
This Second Amendment to the Exclusive Manufacturing, Supply and Distribution Agreement dated August 23rd, 2010 as amended on September 6th, 2012 by and between Baxter Healthcare Corporation having a place of business at One Baxter Way, Westlake Village, California 91361 (hereinafter “Baxter”) and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter “Kamada”) (the "Agreement") is entered into as of this 14th day of May, 2013 (the "Effective Date"). Baxter and Kamada shall collectively be referred to as the “Parties”.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) made as of April 14th, 2013, by and among Kamada Ltd., an Israeli company (the "Company") and the individuals and the entities identified in Schedule 1 attached hereto (the “Shareholder”).
